Skip to main content

Table 3 Antibiotic resistance patterns of Gram-negative bacteria isolated from blood cultures among patients referred to Clinical Bacteriology and Mycology laboratory

From: Bacterial and fungal profile, drug resistance pattern and associated factors of isolates recovered from blood samples of patients referred to Ethiopian Public Health Institute: cross-sectional study

Bacterial isolate

CAZ

MEM

SXT

AMC

TZP

CRO

FEP

AMK

GEN

TOB

CIP

CHL

B. cepacia

65 (4.62)

65 (0)

65 (1.53)

NT

NT

NT

NT

NT

NT

NT

NT

NT

K. pneumoniae

21 (76.2)

21 (52.4)

21 (85.7)

20 (60)

19 (31.6)

21 (81)

21 (66.7)

21 (0)

20 (65)

21 (84.2)

6 (83.3)

21 (47.7)

Acinetobacter spp.

7 (57.1)

7 (71.4)

NT

NT

7 (57.2)

7 (42.9)

7 (42.9)

7 (0)

7 (71.4)

7 (71.4)

6 (100)

NT

E. coli

3 (33.3%)

3 (0)

3 (33.3)

3 (33.3)

3 (0)

3 (66.7)

3 (66.7)

3 (0)

3 (33.3)

2 (50)

1 (0)

3 (0)

K. ozaenae

3 (66.7)

3 (0)

3 (66.7)

3 (0)

3 (0)

3 (100)

3 (33.3)

3 (0)

3 (33.3)

3 (100)

1 (0)

3 (33.3)

Pseudomonas spp.

3 (0)

3 (0)

NT

NT

3 (0)

NT

3 (33.3)

3 (0)

3 (0)

3 (0)

2 (0)

NT

E. cloacae

2 (50)

2 (0)

2 (100)

2 (100)

2 (0)

2 (0)

2 (0)

2 (0)

2 (100)

2 (100)

 

2 (0)

E. aerogenes

1 (100)

1 (0)

1 (100)

NT

1 (0)

NT

NT

NT

NT

1 (0)

1 (0)

1 (100)

  1. CAZ ceftazidime; MEM meropenem; SXT trimethoprim–sulphamethoxazole; AMC amoxicillin–clavulanic acid; TZP piperacillin–tazobactam; CRO ceftraxone; FEP cefipime; AMK amikacin; GEN gentamycin; TOB tobramycin; CIP ciprofloxacin; CHL chloramphenicol; NT not tested